VALERIE LEITKO: Open Payments
NPI 1336318583 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,739 in 84 payments from 20 companies in 2025. Trend: 2023 $1,794 · 2024 $2,204 · 2025 $1,739
Food & beverage: $1,739
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $400 |
| AstraZeneca Pharmaceuticals LP | 11 | $257 |
| PFIZER INC. | 10 | $193 |
| Novo Nordisk Inc | 9 | $191 |
| Amgen Inc. | 8 | $146 |
| GlaxoSmithKline, LLC. | 5 | $113 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $78 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Merck Sharp & Dohme LLC | 2 | $45 |
| Exact Sciences Corporation | 2 | $35 |
Products named: VRAYLAR, BREZTRI, NURTEC ODT, OTEZLA, Wegovy, CAPLYTA, SHINGRIX, REXULTI.
Industry payments across NV — which companies pay providers there.
